This document discusses methods for assessing drug effects on renal and gastrointestinal systems in safety pharmacology studies. For renal function, in vivo mammalian models using rats and dogs are commonly used to assess glomerular function through clearance tests, tubular function through urine analysis, and hemodynamic function through blood flow measurements. In vitro and in silico models are also discussed. For gastrointestinal function, methods described include assessing gastric emptying and intestinal motility using in vitro tissue/organ baths and in vivo animal models, measuring gastric secretion in cell preparations and ligated rats, modeling nausea and emesis in ferrets and dogs, and measuring absorption in Caco-2 cell cultures and perfused intestinal segments of rats.
Safety pharmacology is a branch of pharmacology with its aim to predict the potential clinical risk profile of new chemical entities (NCEs).
It has the ability to predict the potential off-target drug effects on major organ systems which are associated with exposure in the therapeutic range and above.
As an essential part of the spectrum of drug discovery and development, safety pharmacology studies are generally conducted to determine the relative drug effect on main organs, including respiratory system, central nervous system, and cardiovascular system.Safety pharmacology is an essential part of the drug development process that aims to identify and predict adverse effects prior to clinical trials.
SP studies are described in the international conference on harmonization (ICH) S7A and S7B Guidelines.
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
ICH is the “International Conference on Harmonization of
Technical Requirements for Registration of Pharmaceuticals for
Human Use”
ICH is a joint initiative involving both regulators and research based industry representatives of the EU, Japan and the US in
scientific and technical discussions of the testing procedures required
to assess and ensure the safety, quality and efficacy of medicines
Safety pharmacology is a branch of pharmacology with its aim to predict the potential clinical risk profile of new chemical entities (NCEs).
It has the ability to predict the potential off-target drug effects on major organ systems which are associated with exposure in the therapeutic range and above.
As an essential part of the spectrum of drug discovery and development, safety pharmacology studies are generally conducted to determine the relative drug effect on main organs, including respiratory system, central nervous system, and cardiovascular system.Safety pharmacology is an essential part of the drug development process that aims to identify and predict adverse effects prior to clinical trials.
SP studies are described in the international conference on harmonization (ICH) S7A and S7B Guidelines.
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
ICH is the “International Conference on Harmonization of
Technical Requirements for Registration of Pharmaceuticals for
Human Use”
ICH is a joint initiative involving both regulators and research based industry representatives of the EU, Japan and the US in
scientific and technical discussions of the testing procedures required
to assess and ensure the safety, quality and efficacy of medicines
Toxicity is the science dealing with properties, action, toxicity, fatal dose detection or interpretation of result of toxicological analysis & treatment of poison.
Toxicity studies helps to avoid adverse effect and enhance the safety of drug.
This slide provides the information about toxicity screening on experimental animals.
Dermal Irritation and Dermal Toxicity Studies Dinesh Gangoda
Dermal irritation and Corrosion test guidelines 204.
Dermal irritation is the production of reversible damage of the skin following the application of a test chemical for up to 4 hours.
Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology should be considered to evaluate questionable lesions. [1]
Dermal corrosion is the production of irreversible damage of the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test chemical for up to four hours.[2]
REFERENCES
OECD/OCDE, Test No. 404: ‘‘Acute Dermal Irritation/Corrosion’’, 28 July 2015 OECD Publishing, peris, Page no, 1- 8.
Robert A., Turner., Screening Methods in Pharmacology; 1st edition; Academic press an imprint of Elsevier, pp, 279- 281.
OECD Guideline for testing of chemicals (1981). ‘‘Repeated Dose Dermal Toxicity’’, 21/28- day Study.
IND (Investigational New Drug) industrial perspectiveAYESHA NAZEER
Describing the Industry's/sponsor's/drug manufacturers' perspective of the Investigational New Drug Application (IND) program based on the survey conducted by the Office Of Inspector General (OIG).
Toxicity is the science dealing with properties, action, toxicity, fatal dose detection or interpretation of result of toxicological analysis & treatment of poison.
Toxicity studies helps to avoid adverse effect and enhance the safety of drug.
This slide provides the information about toxicity screening on experimental animals.
Dermal Irritation and Dermal Toxicity Studies Dinesh Gangoda
Dermal irritation and Corrosion test guidelines 204.
Dermal irritation is the production of reversible damage of the skin following the application of a test chemical for up to 4 hours.
Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology should be considered to evaluate questionable lesions. [1]
Dermal corrosion is the production of irreversible damage of the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test chemical for up to four hours.[2]
REFERENCES
OECD/OCDE, Test No. 404: ‘‘Acute Dermal Irritation/Corrosion’’, 28 July 2015 OECD Publishing, peris, Page no, 1- 8.
Robert A., Turner., Screening Methods in Pharmacology; 1st edition; Academic press an imprint of Elsevier, pp, 279- 281.
OECD Guideline for testing of chemicals (1981). ‘‘Repeated Dose Dermal Toxicity’’, 21/28- day Study.
IND (Investigational New Drug) industrial perspectiveAYESHA NAZEER
Describing the Industry's/sponsor's/drug manufacturers' perspective of the Investigational New Drug Application (IND) program based on the survey conducted by the Office Of Inspector General (OIG).
In-vitro and in-vivo methods of diuretics & antihypertensive final.pptxAishwaryaPatil697206
This ppt contains in-vitro and in-vivo preclinical methods of diuretics and antihypertensive drugs. It contains classification as well as mechanism of action.
Assessing gastrointestinal toxicity using human tissues bioptaBiopta Inc.
Many drugs adversely affect the gastrointestinal system. This presentation describes the use of ethically-donated human tissue samples in the prediction of drug-induced gastrointestinal toxicity and will be of interest to scientists involved in drug discovery and development.
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...bhupenkalita7
This PPT includes a brief introduction of in silico models for simulation of GI absorption of drugs, principles involved in the dvelopment of computational models for in silico pharmacokinetic studies related to absorption of drugs from GI tract.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. Tier 2 Safety P’cological Studies
• Also called as Supplemental
pharmacological studies.
• Used to access potential adverse
pharmacodynamic effect organ
system function not addressed by
core battery studies.
• It includes
Renal/Urinary system
Gastrointestinal System
Other Organ system
Skeletal system
Immune and endocrine functions
3. Renal studies in safety pharmacology
• The kidney is a complex excretory organ
• Playing role in
Fluid and electrolyte balance
Control of blood pressure
Removal of waste products
Drug disposition
Endocrine function
4. • 30-40% drugs invented can cause
renal injury
• Still the safety P’cological studies
related to renal system in preclinical
system is small
Renal studies in safety pharmacology
5. Methods to assess drug effects on Renal Function
• It should cover
Excretory function
Hemodynamic function
Endocrine aspects
• In-vivo models are frequently used.
6. Models Employed
• In-Vivo Mammalian models
• In-Vivo Non-Mammalian models
• In-Vitro Models
• In-Silico Models
Glomerular Function
Tubular Function
Hemodynamic Function
7. In-Vivo Mammalian Models
• Rats, Dogs, Pigs are commonly used
• Conscious, Freely moving animals
• Analysis of urine and plasma are done.
• Urinary bladder catherterization and metabolism cage
are used
9. a. Glomerular Function
• Clearance measurement of endogenous and exogenous small molecules
(urea, creatinine, 2-MPT, inulin, cystatin C, iohexol, or iodixanol)
• analysis of plasma and urine samples
• The noninvasive clearance (NIC)-kidney device that when mounted on the
back of laboratory animals enables the transcutaneous measurement of the
elimination kinetics of the fluorescent renal marker FITC-sinistrin
• This allows the measurement of the clearance of FITC-sinistrin from the
plasma in real time without the need for any blood Sampling
10.
11. b. Tubular Function
• allows the identification of the
functional status of particular
nephron segments
• includes visual assessment of urine
(color, clarity), volume, specificgravity
or osmolality, pH, quantitative or
semiquantitative protein, and glucose
content.
• Dipstick test strips assess other
parameters, such as ketones,
bilirubin, urobilinogen, hemoglobin,
etc
12.
13. c. Hemodynamic Function
1.Direct renal blood flow measurment
• requires the placement of a flow probe around the renal
artery
• conducted in large animal species such as dogs,(mini-)pigs, and
nonhuman primates
• usually coupled with systemic blood pressure monitoring, using a pressure
catheter placed into an artery
• Another hemodynamic endpoint is the renal vascular resistance (RVR),
calculatedas the ratio between RBF and mean arterial pressure (MAP)
• RVR can be increased in case of renal dysfunction or in case of systemic hypertension
14.
15. 2. Indirect renal blood flow measurement
• para-aminohippuric acid(PAH) clearance test
• all PAH passing through the kidneys appears in the urine
• PAH clearance is directly proportional to the rate of plasma
flow through the kidneys
• If the hematocrit is known, the total renal blood flow can
be easily calculated from the eRPF value
16. In Vivo Non-mammalian Models
• The zebrafish (Danio rerio) larva has gained increasing interest
over the last decade as an alternative to mammalian in vivo
models.
• The zebrafish kidney is genetically and morphologically close
to that of mammals
• measurements of FITC-inulin intensity in the caudal artery and
excreted FITC-inulin
• validated using gentamicin and high salt loading
• high-throughput screening, visual transparency, low cost, and
genetic manipulation
17. • The kidney is highly complex, composed of a filter unit and a tubular segment, together
containing over 20 different cell types.
• Nephrotoxicants cause injury by selectively injuring specific cell types or by nonselectively injuring
multiple cell types within the kidney, depending on their mechanism of action
• Assessment of the potential nephrotoxic effects of pharmaceutical compounds on different
components of the kidney therefore requires the use of different model systems.
• in vitro model that recapitulates the in vivo response of renal cells to nephrotoxicants requires
appropriate expression of the transporters and receptors that interact with the drug of interest.
• In addition to detecting expression of transporters at the transcript and protein level by
quantitative PCR and immunohistochemistry, the function of transporters and endocytic receptors
can be investigated by assessing the effect of fluorescent substrates and transport inhibitors
In Vitro Models
18. In Silico Models
• The SAPHIR project (a Systems Approach for Physiological
Integration of Renal, cardiac, and respiratory functions),
initiated in 2008
• targeting the short- and long-term regulation of blood
pressure, body fluids, and homeostasis of the major solutes
• for renal and urinary disorders, the predictivity was not very
high
20. Gastrointestinal Safety Pharmacology
• 2-3% discontinuation of drug project
• Related ADRs and AEs are not life threatening but
hampers quality of life for patients
• 18% of total ADRs
• Overuse of NSAIDs in US is a reason behind >1,00,000
hospitalizations and 17,000 deaths in a year (2003)
• Hence there is a need for improved and more extensive
GI Screening
21.
22. Methods to Assess Drug Effects on Gastrointestinal
Function
1. Assessment of Gastric Emptying and Intestinal Motility
2. Assessment of Gastric Secretion
3. Models of Nausea and Emesis
4. Models of Gastrointestinal Absorption
23. Assessment of Gastric Emptying and Intestinal Motility
In Vitro Models
• subcellular, cellular, tissue, or whole organ to study the pharmacological effects
and mechanism of action of drugs on GIT
• Stomachs or isolated segments of GIT from small laboratory animals can be
suspended in organ baths to investigate the mechanisms underlying a novel drug
target and to validate physiological or pharmacological responses. Typically
muscular strips or whole segments from the GIT are suspended in organ baths
containing a suitable nutrient solution held at 37 C and gassed with carbogen
• study the enteric nerves is done by measuring changes in motility caused by
electrical field stimulation (EFS)
24. In Silico Organ Modeling
• Computational fluid dynamic (CFD) techniques (Ferrua and Singh 2010) predict the dynamic effects of
luminalcontents on GI motility, luminal content mixing, and propulsion
• This model showed a complex and highly three-dimensional flow profile during gastric contraction
25. In Vivo Models
• In rodents by administering meals containing markers such as phenol
red, barium sulfate (BaSO4), or charcoal, subsequent to the
administration of the test compound. The test meals can be used either
as an indicator of liquid (phenol red) or solid transport (charcoal,
BaSO4).
• For gastric emptying assessment, the stomach is weighed,after definite
time as its weight directly correlates with its content. Any difference in
the gastric weight between treatment groups indicates altered gastric
emptying.
26. • For intestinal motility assessment, the intestines are removed (usually
from duodenum to ileum) and the length of intestine filled with charcoal
or BaSO4 is measured and compared to the full gut length by visual
inspection.
• The percentage of intestinal length filled by the test meal is proportional
to the intestinal transit. Any difference between treatment groups
indicates an alteration in the intestinal motility (increase or decrease).
• With phenol red, the intestinal transit is evaluated by measuring the
spectral absorbance in specific subparts of the gut.
27. Assessment of Gastric Secretion
In Vitro Models
• performed on mucosal cell preparation from stomach mucosa obtained by enzyme
dispersion and separated by centrifugation to separate parietal cells (H+ secreting
cells)
• Measures the H+ concentration and pepsin secretion in the gastric effluent
28. In Vivo Models
• Rats fasted for 24 hrs prior to pyloric ligation.
• Randomly divided into 5 groups of 3 animals each.
Group I : Control vehicle
Group II : Standard drug (Omeprazole)
Group III : ‘x’ concentration of test drug
Group IV : ‘2x’ concentration of test drug
Group V : ‘ 4x’ concentration of test drug
• Drugs administered once for 2 days and 30 mins prior to ligation
• Rats anesthetized with ether.
• Pyloric ligation procedure done.
• Rats placed in separate cages and allowed to recover.
• 19 hrs after pyloric ligation, animals sacrificed by decapitation.
Pyloric ligation method
29. Models of Nausea and Emesis
In Vivo Models
• assessed in conscious animal models
• Ferrets and dogs are typically considered to be the best species for the evaluation of
emesis, dogs being usually more sensitive to emetic stimuli compared to humans
• Rats and mice are not able to vomit, but can display some behavioral reactions that
can represent nausea, such as gasping or pica
• Emesis evaluation in dogs, ferrets, or nonhuman primates usually consists of visual
recordings of retching and vomiting events, and possibly premonitory signs such as
licking, during a defined period following compound administration
• The number of events and the latency are the most frequent parameters reported.
30. Models of Gastrointestinal Absorption
In Vitro Models
• Cell culture-based permeability screening models are used for the rapid assessmentof
intestinal permeability of drug candidates
• The human monolayer of colon adenocarcinoma cells (Caco-2) model used to predict
the intestinal absorption of orally administered drugs or measurement of flux of a
marker molecule or active ion transport across epithelial cells.
• NSAID-induced mucosal damage has been demonstrated in gastric mucosa
31. In Vivo Models
• In situ absorption models have been used in the anesthetized rat, with intraluminal
administration of the test drug and collection of inflow and outflow of an isolated
segment of the gut
• In parallel, arterial blood is sampled and the disappearance rate of the substance is
evaluated